Object. The purpose of this report was to provide overall arteriovenous malformation (AVM) hemorrhage rates and, with enhanced statistical power, to elucidate significant risk factors for hemorrhage.
I
ntracranIal hemorrhage from cerebral AVMs is a considerable source of neurological morbidity and mortality. 3, 5, 7 With an accumulating body of AVM natural history data, our understanding of hemorrhage rates and risk factors for hemorrhage continues to evolve. Unfortunately, there is a remarkable degree of heterogeneity in the methods of reporting annual hemorrhage rates as well as overall conclusions about these rates and influencing factors. We performed a meta-analytical review of the literature and here uniformly present annual hemorrhage rates as well as the factors that can affect them.
Methods

Study Selection
Our meta-analysis was performed in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. 16 A PubMed search using the terms "arteriovenous malformation," "AVM," "natural history," "bleed," and "hemorrhage" was performed through January 31, 2012. No publication date or publication status restrictions were imposed. We incorporated English language studies that provided annual hemorrhage rates for AVMs, defined as the ratio of total number of hemorrhages to total number of patientyears of follow-up. In the absence of patient-specific data, we included studies from which we could back-calculate this ratio, defining total patient-years as the product of the number of patients and the mean follow-up period. We both independently assessed eligibility. To enhance the comprehensiveness of our review, references in the reviewed studies were perused and incorporated if our inclusion criteria were met. Studies that did not provide information to allow calculation of an annual hemorrhage rate were excluded. Note that several studies with the same patient population were represented in the literature multiple times as follow-up accrued. To reduce bias, only Natural history of cerebral arteriovenous malformations: a meta-analysis the most recent study was used, except for one population for which the second most recent study was used. 13 This slightly older study provided more hazard ratios for risk factors for hemorrhage, and its analysis covered nearly the same period as the more recent report. 12 In addition, studies calculating annual AVM hemorrhage rates that assumed lesion presence since birth, studies evaluating only subgroups of patients with AVMs, and those providing overall annual hemorrhage rates for patients with any type of vascular malformation were excluded.
Data Extraction
We both independently performed data extraction, which was consistent. We extracted epidemiological data including patient age, patient sex, AVM location, AVM size, AVM drainage pattern, prior rupture, and associated aneurysms. We then calculated the number of hemorrhages and patient-years of follow-up across these studies, also making note of subgroup analyses for annual hemorrhage rates and risk factors. Hazard ratios were extracted for each risk factor.
Data Analysis
Statistical analysis was performed using the rmeta package in R, version 2.11. The primary outcome measure was the first hemorrhage after presentation. To explain variability in the primary outcome, we defined 8 a priori variables: prior hemorrhage, patient sex, patient age, AVM size (< 2.5 or 3 cm vs ≥ 2.5 or 3 cm), presence of any intracranial aneurysm, AVM location (superficial vs deep: brainstem, deep cerebellar, basal ganglia, thalamic, or callosal), exclusive deep venous drainage (deep venous drainage only vs superficial drainage only or superficial and deep venous drainage), and any deep venous drainage (deep drainage only or superficial and deep venous drainage vs superficial venous drainage only). The meta-analyses of hazard ratios were performed using a random-effects approach. Publication bias was assessed using the Egger regression test and rank correlation with the Kendall tau for each categorical factor considered in the Cox proportional hazards regression model. 1 We also analyzed epidemiological factors via a directly adjusted model using a standardized population with the epiR package in R.
Results
Literature Search
Our literature search is illustrated in Fig. 1 . After an initial screening of 2795 articles, 146 full-text articles were perused for eligibility, affording 9 natural history studies, 4 of which provided hazard ratios for AVM risk factors. Across the 9 reviewed natural history studies, there were 3923 patients followed up over 18,423 patientyears, sustaining a total of 484 hemorrhages. 3, 4, 5, 9, 10, 13, 14, 21, 28 
Demographic Details
Demographic data are provided in Table 1 . The mean age at presentation was 33.7 years old (95% CI 31.1-36.2). Forty-five percent of patients were female (95% CI 42%-49%). The most common presentation was hemorrhage, occurring in 52% of patients (95% CI 48%-56%), whereas the second most common presentation was seizure in 27% of patients (95% CI 24%-30%). Twenty-seven percent of AVMs were deep (95% CI 23%-31%) with 53% having deep venous drainage (95% CI 48%-58%). Eighteen percent of AVMs had associated aneurysms (95% CI 15%-21%), approximately half of which occurred on feeding arteries and one-fourth of which occurred in an intranidal or a remote location. Forty percent of AVMs were small (< 2.5 or 3 cm, depending on the study design, 95% CI 35%-45%). Rank correlation did not demonstrate any significant correlation, indicating that there was no significant publication bias. Similarly, for factors in which the Egger regression test was valid, no publication bias was found.
General AVM Rupture Rates
Rupture and rerupture rates are provided in Table 2 . An overall annual hemorrhage rate of 3.0% per year (95% CI 2.7%-3.4%) was seen across these studies, with an initial annual rupture rate of 2.2% (95% CI 1.7%-2.7%) and rerupture rate of 4.5% (range 3.7%-5.5%). Rebleed rates in the 1st year were provided in 4 studies, 5,9,10,28 ranging from 6%-15%. Across prospective studies, the overall annual bleed rate (3.2%, 95% CI 2.8%-3.7%) and unruptured annual bleed rate (2.3%, 95% CI 1.7%-2.9%) were similar; however, the annual rebleed rate was greater-6.7% (95% CI 5.2%-8.4%).
5,21
Risk Factors for AVM Hemorrhage
Hazard ratios for potential risk factors for hemorrhage were provided in 4 studies (Table 3) . 5, 12, 21, 28 Statistically significant risk factors for hemorrhage were prior hemorrhage (HR 3.2, 95% CI 2.1-4.3), deep AVM location (HR 2.4, 95% CI 1.4-3.4), exclusively deep venous drainage (HR 2.4, 95% CI 1.1-3.8), and associated aneurysms (HR 1.8, 95% CI 1.6-2.0). The presence of any deep venous drainage (HR 1.3, 95% CI 0.9-1.75) and female sex (HR 1.4, 95% CI 0.6-2.1) demonstrated a trend toward an increased risk of hemorrhage that was not statistically significant. A small AVM size (< 3 cm) and an older age were not statistically significant risk factors for hemorrhage.
Discussion
Arteriovenous malformation hemorrhage has been associated with long-term neurological morbidity and mortality as high as 35% 3 and 29%, 3 respectively. The attempt to clearly delineate their natural history began decades ago 18 and continues to present a considerable challenge owing to a remarkable degree of heterogeneity not only in study design but also in results. Original studies were derived from surgical series and noted the percentage of patients with hemorrhage over a particular time block. 6, 18, 25 Subsequent analyses then evaluated the prevalence and influence of certain risk factors on hemorrhagic presentation. 22, 23, 26 Modern studies have provided an overall annual hemorrhage rate and, in turn, have detailed the influence of certain risk factors on this rate, providing a clear, reproducible approach to evaluating the natural history of AVMs. 5, 9, 13, 22, 28 Nevertheless, despite this simple methodology, a remarkable degree of heterogeneity in results from these natural history studies is quite evident. Authors have presented conflicting annual hemorrhage rates and risk factors for hemorrhage, even in updated analyses of the same patient database. 5, 9, 17, 24 This is probably in part due to the limited statistical power of an individual study, prompting our meta-analysis (Table 4) .
Overall Hemorrhage Rate
Our analysis of 9 natural history studies demonstrated an AVM annual hemorrhage rate of 3.0% (95% CI 2.7%-3.4%). This blanket value is highly influenced by the factors discussed below and may have very little meaning for particular AVMs; therefore, it is crucial to evaluate individual AVM characteristics that will influence this rate.
Prior AVM Hemorrhage
Ubiquitous in cerebrovascular neurosurgery is the maxim that a previously ruptured vascular malformation is more likely to rupture again. 5, 8, 9 This tenet was challenged by the original AVM study of Ondra et al. 17 that demonstrated no increased risk of bleeding among ruptured AVMs. Another robust prospective study from Toronto also did not document a statistically significant impact of prior hemorrhage on subsequent bleeding. 24 It is crucial to note that both of these reports have been overturned by more recent analyses of the same cohorts with longer follow-ups-the studies of Hernesniemi et al. 9 and da Costa et al., 5 respectively. Thus, there is essentially unanimous consensus that prior AVM hemorrhage is a significant risk factor for subsequent bleeding, with our meta-analysis demonstrating an HR of 3.2 (95% CI 2.1-4.3). We found that unruptured AVMs had an overall annual risk of hemorrhage of 2.2% (95% CI 1.7%-2.7%), whereas ruptured AVMs had an overall annual rupture rate of 4.5% (95% CI 3.7%-5.5%). Furthermore, rerupture rates within the 1st year ranged from 6%-15%. 5, 9, 10, 28 Thus, the oft cited "6% rebleed rate in the first year" from one early 1983 study 7 should be viewed as a minimum rather than a mean value. This first-year rate has profound implications for both the timing of surgical therapy and the choice of radiosurgery for ruptured AVMs, that is, half of the AVMs that we face. 5, 9, 10, 28 
Associated Aneurysms
Eighteen percent of patients with AVMs also have aneurysms, approximately half of them occurring on feeding arteries. Numerous studies have demonstrated a strong correlation between hemorrhagic presentation and associated aneurysms. 22, 23, 26 However, it is notable that the impact of associated aneurysms on AVM hemorrhage rate is not as well represented in natural history literature involving subsequent patient follow-up. This finding underscores the implicit selection bias in which such AVMs are being treated early. Unfortunately, because of this bias, the impact of associated aneurysms on AVM rupture risk is probably never to be fully elucidated. The original study by Brown et al. 2 demonstrated an annual hemorrhage rate of 8.3% for patients with AVMs and associated aneurysms as compared with 2.4% for those without aneurysms. The recent study by da Costa et al. 5 documented an annual hemorrhage rate of 6.93% for patients with AVMs and associated aneurysms as compared with 3.99% for the remainder of the cohort. Indeed, our meta-analysis revealed that associated aneurysms were a statistically significant risk factor for hemorrhage with an HR of 1.8 (95% CI 1.6-2.0). Although our reviewed studies did not provide hazard ratios for specific aneurysm subtypes after multivariate analysis, da Costa et al. 5 reported HRs of 1.7 (p = 0.03) and 2.1 (p = 0.03) for feeding artery and intranidal aneurysms, respectively, after a univariate analysis. In this analysis, remote aneurysms did not significantly increase the risk of hemorrhage. An earlier study from these same authors provided quantified annual rates of hemorrhage of 9.8% and 5.3% for AVMs with intranidal and remote aneurysms, respectively. 19 In a univariate analysis, Stapf et al. 21 demonstrated a trend toward a greater risk of hemorrhage for AVMs with feeding artery aneurysms (HR 1.78, 95% CI 0.91-3.46) that was not seen for AVMs with intranidal aneurysms (HR 0.64, 95% CI 0.19-2.10).
Deep Venous Drainage and Deep Location
Fifty-three percent of AVMs in our reviewed studies had deep venous drainage (95% CI 48%-58%), whereas 27% had a nidus in a deep location (95% CI 23%-31%). Given that each of these factors is unappealing from a surgical perspective, it is not surprising that we have more natural history follow-up for these risk factors. The increased pressure of the deep venous system and resultant increased pressure gradients across the AVM nidus have long been postulated to affect hemorrhage rates for these lesions. 5, 9 Furthermore, although not formally confirmed in natural history studies, from a similar mechanism, it is likely that stenosis of the drainage system is associated with an increased risk of hemorrhage. 15, 27 This is underscored by the oft reported greater annual hemor- rhage rate for AVMs with deep venous drainage, ranging from 2.4% to 5.4% 5, 9, 21, 28 and increasing to 7.2%-11.4% for previously ruptured deep AVMs. 21, 28 From our metaanalysis, the HR was 2.4 (95% CI 1.1-3.8) for exclusively deep venous drainage and 1.3 (95% CI 0.9-1.75) for any deep drainage.
Although often associated with deep venous drainage, a deep location was also a consistent independent risk factor for AVM hemorrhage (HR 2.4, 95% CI 1.4-3.4). Some have postulated an association of deep AVM location with a greater proclivity toward perforator involvement and a resultant higher rupture rate owing to the fragility of these vessels. 9 Alternatively, a greater association with ventricular representation is another possibility, with the absence of an adjacent "tamponade" effect from adjacent tissue on the lesion. Reported annual rupture rates for deep AVMs ranged from 3.1% to 4.4%, 9, 21, 28 increasing to 11.4%-14.8% for those with prior rupture. 21, 28 Other Factors A trend toward a greater risk of hemorrhage was seen in female patients (HR 1.4, 95% CI 0.6-2.1), although a small AVM size and an older patient age were not significantly associated with an increased risk of hemorrhage. Early natural history studies noted a small AVM size as a significant risk factor for hemorrhage, 7, 10, 11, 20 with one in particular demonstrating greater feeding artery pressures in these lesions; 20 however, these studies were limited by their retrospective nature, and some reached this conclusion in an analysis of mode of presentation rather than follow-up. 11 While a small AVM size as a risk factor for hemorrhagic presentation has been substantiated in modern natural history studies, 21, 28 it must be distinguished from annual risk of hemorrhage. The former may simply reflect the fact that smaller AVMs are less likely to present with seizures or steal phenomena. Our reviewed studies evaluating the annual risk of hemorrhage of small AVMs presented conflicting results, with one study demonstrating a subtle trend toward a greater hemorrhage rate 21 and another showing a significantly decreased hemorrhage rate for these lesions. 9 Conflicting results were also seen for an older patient age, although no HRs > 1.2 were reported for this potential risk factor. 5 The one study presenting it as a statistically significant risk factor for hemorrhage reported an HR of only 1.1.
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Study Limitations
Although the incorporated studies adhered to a similar follow-up approach using time from presentation until the last follow-up or treatment, all but two 9,13 drew from a cohort of patients presenting to a selected hospital or group of hospitals and were not population based. All studies were limited by selection bias, as patients with AVMs exhibiting more "dangerous" characteristics may be selected out for early AVM treatment, potentially lowering the observed overall annual hemorrhage rate. As previously mentioned, this is particularly relevant for AVMs with associated aneurysms since the natural history follow-up time may be more limited. Only 4 incorporated studies documented mean follow-up periods of at least 10 years, 4,9,10,14 whereas the median follow-up was as brief as 102 days in one of our incorporated studies. 21 In addition, the number of patients lost to follow-up was often not addressed.
Selective outcome reporting of statistically significant results may have limited our analysis; however, all hemorrhage rates and hazard ratios provided in each study were incorporated into our analysis.
Although we found no significant publication bias via log-rank correlation, the modern AVM natural history literature is dominated by the constantly increasing, large Helsinki, 9 Columbia, 21 Toronto, 5 and University of California, San Francisco, databases, 13 making it more difficult to publish studies of smaller, new patient cohorts. Our methods were limited by our English language restriction and our use of one database. However, we intentionally did not provide a start date for our PubMed search and used very broad search terms. We also perused references in all full-text articles reviewed.
It is crucial to emphasize that the majority of patients in all reviewed studies had symptomatic AVMs, limiting the external validity of this study to patients with truly incidental AVMs. Although modern studies ubiquitously stratify annual AVM hemorrhage rates by rupture status of the lesion, 5, 9, 13, 21, 28 future studies should provide annual hemorrhage rates for incidental AVMs, as the more prevalent use of advanced imaging modalities for wider indications will continue to increase the prevalence of this important patient cohort.
Conclusions
We demonstrated an overall annual hemorrhage rate of 3.0% for AVMs (95% CI 2.7%-3.4%). The annual rebleed rate was calculated as 4.5% (95% CI 3.7%-5.5%) and at least 6% in the 1st year after hemorrhage. In addition to prior hemorrhage, a deep AVM location, exclusively deep venous drainage, and associated aneurysms are significant risk factors for AVM hemorrhage. Any deep venous drainage and female sex were risk factors demonstrating a trend toward a greater risk of hemorrhage, whereas a small AVM size and older patient age were not significant risk factors for hemorrhage.
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